# Daratumumab (Genetical Recombination) I.V. Infusion 400mg (ダラザレックス点滴静注４００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291437A2024). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291437A2024
- **Product name (Japanese):** ダラザレックス点滴静注４００ｍｇ
- **English title:** Daratumumab (Genetical Recombination) I.V. Infusion 400mg
- **Active ingredient:** ダラツムマブ（遺伝子組換え）
- **Active ingredient (INN):** Daratumumab (Genetical Recombination)
- **Strength / unit:** ４００ｍｇ２０ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Janssen Pharmaceutical (ヤンセンファーマ)
- **NHI price (reference only):** JPY 187970 per ４００ｍｇ２０ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291437A2024
- **JSON:** https://www.nifujipharma.com/api/drugs/4291437A2024

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Daratumumab%20(Genetical%20Recombination)%20I.V.%20Infusion%20400mg%20(%E3%83%80%E3%83%A9%E3%82%B6%E3%83%AC%E3%83%83%E3%82%AF%E3%82%B9%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%94%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291437A2024#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Daratumumab (Genetical Recombination)

- [Daratumumab (Genetical Recombination) I.V. Infusion 100mg (ダラザレックス点滴静注１００ｍｇ)](https://www.nifujipharma.com/drugs/4291437A1028) — １００ｍｇ５ｍＬ１瓶, Janssen Pharmaceutical